Methods and compositions for reducing the proliferation of gram positive bacteria

US9913854B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-9913854-B2
Application numberUS-201314388685-A
CountryUS
Kind codeB2
Filing dateMar 14, 2013
Priority dateMar 28, 2012
Publication dateMar 13, 2018
Grant dateMar 13, 2018

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Provided herein are methods for inducing cell death in a gram positive bacterium and methods for reducing the proliferation of a gram positive bacterium that include contacting a gram positive bacterium with a dye (e.g., an azo dye) and a TarO inhibitor. Also provided are methods of treating a subject having a gram positive bacterial infection that include administering to a subject having a gram positive bacterial infection a dye (e.g., an azo dye) and a TarO inhibitor. Also provided are compositions containing a dye (e.g., an azo dye) and a TarO inhibitor, and kits containing at least one of these compositions.

First claim

Opening claim text (preview).

The invention claimed is: 1. A method for inducing cell death in a gram positive bacterium or reducing the proliferation of a gram positive bacterium, the method comprising contacting a gram positive bacterium with Congo Red and tunicamycin in amounts sufficient to induce cell death in the gram positive bacterium or amounts sufficient to reduce the proliferation of the gram positive bacterium. 2. The method of claim 1 , wherein the gram positive bacterium is present in a mammal. 3. The method of claim 1 , wherein the gram positive bacterium is present in vitro. 4. The method of claim 3 , wherein the gram positive bacterium is present in a cell culture, is present in or on a food composition, or is present in a pharmaceutical or cosmetic composition. 5. The method of claim 1 , wherein the gram positive bacterium is a coccus gram positive bacterium. 6. The method of claim 5 , wherein the coccus gram positive bacterium is from the Streptococcus, Enterococcus , or Staphylococcus genus. 7. The method of claim 1 , wherein the gram positive bacterium is a bacillus gram positive bacterium. 8. The method of claim 7 , wherein the bacillus gram positive bacterium is from the Cornebacterium, Listeria, Bacillus , or Clostridium genus. 9. A method of treating a subject having a gram positive bacterial infection, the method comprising administering to the subject having a gram positive bacterial infection Congo Red and tunicamycin in amounts sufficient to decrease the population of gram positive bacteria in the subject. 10. The method of claim 9 , wherein the population of gram positive bacteria comprises coccus gram positive bacteria. 11. The method of claim 10 , wherein the coccus gram positive bacteria are from the Streptococcus, Enterococcus , or Staphylococcus genus. 12. The method of claim 9 , wherein the population of gram positive bacteria comprises bacillus gram positive bacteria. 13. The method of claim 12 , wherein the bacillus gram positive bacteria are from the Cornebacterium, Listeria, Bacillus , or Clostridium genus. 14. The method of claim 1 , wherein the concentration of Congo Red is less than 1024 mg/L. 15. The method of claim 9 , wherein the amount of the tunicamycin is not toxic to the subject.

Assignees

Inventors

Classifications

  • Amino-benzenes · CPC title

  • from other coupling components · CPC title

  • Dye preparations of special physical nature; Tablets, films, extrusion, microcapsules, sheets, pads, bags with dyes · CPC title

  • Azo (—N=N—), diazo (=N2), azoxy (>N—O—N< or N(=O)—N<), azido (—N3) or diazoamino (—N=N—N<) compounds · CPC title

  • containing three or more hetero rings · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US9913854B2 cover?
Provided herein are methods for inducing cell death in a gram positive bacterium and methods for reducing the proliferation of a gram positive bacterium that include contacting a gram positive bacterium with a dye (e.g., an azo dye) and a TarO inhibitor. Also provided are methods of treating a subject having a gram positive bacterial infection that include administering to a subject having a gr…
Who is the assignee on this patent?
Massachusetts Eye & Ear Infirmary
What technology area does this patent fall under?
Primary CPC classification A61K31/706. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 13 2018 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).